Last Rebalance

Scottish Mortgage Investment Trust PLC (SMT.L) · DECREASE · Net Flow +£3,734.31

Analysis: SMT provides broad exposure to unlisted private AI scale-ups but trades at a wide discount to net asset value reflecting market skepticism over private asset marks.

Bull Case: Rapid valuation uplifts in private holdings like SpaceX and ByteDance alongside narrowing trust discount.

Bear Case: Prolonged high interest rates depressing private market valuations and stalling initial public offerings.

Reason: Reduced weight to lower portfolio-level beta and manage potential private asset markdown volatility.

Key Risk: Persistent net asset value discount and high exposure to pre-profit technology businesses.

RELX PLC (REL.L) · INCREASE · Net Flow -£1,155.82

Analysis: RELX successfully integrates generative AI across its legal and scientific workflows, commanding premium pricing power via non-replicable proprietary data sets.

Bull Case: Accelerated adoption of premium Lexis+ AI tools driving multi-year margin expansion and recurring revenue growth.

Bear Case: Open-source legal AI tools providing viable cheap alternatives and disrupting legal publishing market share.

Reason: Increased allocation due to high quality of earnings, superior pricing power, and strong risk-adjusted returns.

Key Risk: High base valuation leaves little room for execution missteps in digital tool rollout.

London Stock Exchange Group PLC (LSEG.L) · INCREASE · Net Flow -£1,192.11

Analysis: The multi-year Microsoft partnership embeds advanced workspace analytics directly into financial enterprise workflows, boosting stickiness.

Bull Case: Widespread roll-out of new cloud data platforms driving massive cross-selling opportunities across global banking clients.

Bear Case: Integration delays of legacy databases slowing down planned annual recurring revenue targets.

Reason: Increased weight to exploit structural demand for institutional financial data required to train proprietary models.

Key Risk: Complex technical execution risks across massive multi-asset data architectures.

AstraZeneca PLC (AZN.L) · DECREASE · Net Flow +£1,278.39

Analysis: AstraZeneca leverages computational models to shorten oncology clinical trial phases, improving pipeline asset conversion metrics.

Bull Case: Breakthrough data outputs across major phase trials accelerating commercial asset registration.

Bear Case: Unexpected clinical safety trial failures causing substantial development write-downs.

Reason: Reduced allocation to fund higher-conviction data providers while maintaining defensive pharmaceutical diversification.

Key Risk: Inherent clinical development risks and regulatory hurdles in global drug pipelines.

Fundsmith Equity T Acc (0P0000RU7W.L) · DECREASE · Net Flow +£1,255.42

Analysis: Fundsmith focuses on defensive high-return on capital business models, providing exposure to international megacaps.

Bull Case: Resilient underlying consumer demand and cash flow generation across key global portfolio holdings.

Bear Case: Underperformance relative to tech-concentrated indices due to deliberate funding exclusions of speculative models.

Reason: Reduced exposure to allocate capital into directly listed pure-play technology alternatives.

Key Risk: Concentration in consumer staples and valuation risk across highly valued cash compounds.

The Sage Group plc (SGE.L) · INCREASE · Net Flow -£1,900.74

Analysis: Sage incorporates automated accounting assistants directly within mid-market cloud solutions, defending high retention rates.

Bull Case: High subscription conversion rates driving multi-year software-as-a-service margin expansion.

Bear Case: Aggressive promotional pricing from competitors targeting key small-and-medium enterprise clients.

Reason: Increased position given solid execution in cloud services and defensive software-as-a-service economics.

Key Risk: Slowing small-business formation rates hurting net customer addition metrics.

iShares Core MSCI Emerging Markets IMI UCITS ETF (EMIM.L) · EXIT · Net Flow +£2,444.54

Analysis: EMIM contains broad geopolitical risks and structural macroeconomic drag that dilutes pure tech sector gains.

Bull Case: Sudden cyclical recovery across non-tech emerging market industrial segments.

Bear Case: Escalating trade tensions and currency volatility damaging manufacturing export margins.

Reason: Exited to eliminate global macroeconomic drag and recycle capital into pure structural AI software plays.

Key Risk: Geopolitical friction and structural growth decelerations within emerging market baskets.

Ocado Group PLC (OCDO.L) · EXIT · Net Flow +£651.76

Analysis: Ocado features high cash burn and weak path to profitability, making its robotics thesis too speculative under current macro constraints.

Bull Case: Unanticipated acceleration of global logistics contract wins with Tier 1 supermarkets.

Bear Case: Continued cash-burn constraints leading to dilutive capital raises or balance sheet restructuring.

Reason: Exited to eliminate speculative unprofitability and improve portfolio risk-adjusted return metrics.

Key Risk: Severe balance sheet strain and vulnerability to capital market funding costs.

Moneysupermarket.com Group PLC (MONY.L) · ENTER · Net Flow -£2,557.89

Analysis: Moneysupermarket uses algorithmic personalization engines to improve user search conversion, generating clean free cash flow.

Bull Case: Automated switching tools driving massive structural customer retention and high margin volumes.

Bear Case: Changes to organic search traffic algorithms reducing overall user acquisition volumes.

Reason: Replaces Ocado to introduce structural cash-generative software business with clear AI application.

Key Risk: Regulatory scrutiny over retail insurance distribution commission frameworks.

Spire Healthcare Group plc (SPI.L) · ENTER · Net Flow -£2,557.89

Analysis: Spire Healthcare Group plc leverages record demand in self-pay private medicine and an expanding primary care footprint to counteract severe public sector volatility, driving growth in adjusted free cash flow.

Bull Case: Unprecedented NHS waiting lists accelerating long-term private medical insurance (PMI) adoption and structural momentum in high-margin self-pay procedures.

Bear Case: Severe budgetary restrictions across local NHS Integrated Care Boards causing a sharp drop in public sector commissioning volumes and underutilising hospital capacity.

Reason: Operates as a highly defensive, asset-backed healthcare business with imminent corporate catalyst potential via a recommended £1 billion private equity takeover proposal.

Key Risk: Sustained margin compression from domestic wage inflation, rising national insurance costs, and unpredictable government tariff resets.